[Neuromuscular diseases associated with HIV-1 infection].
Mukai
Eiichirou
E
Department of Neurology, Nagoya Medical Center, 4-4-1 Sannomaru, Naka-ku, Nagoya 460-0001, Japan.
D019380:Anti-HIV Agents / Q000009:adverse effects; D003586:Cytomegalovirus Infections / Q000209:etiology; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D009443:Neuritis / Q000209:etiology; D009468:Neuromuscular Diseases / Q000139:chemically induced / Q000209:etiology*; D010523:Peripheral Nervous System Diseases / Q000209:etiology*; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000209:etiology; D016047:Zalcitabine / Q000009:adverse effects; D015215:Zidovudine / Q000009:adverse effects
D019380:Anti-HIV Agents; D015215:Zidovudine; D016047:Zalcitabine